Found: 59
Select item for more details and to access through your institution.
Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad474
- By:
- Publication type:
- Article
Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period—United States, 1 January 2022 to 31 March 2022
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1753, doi. 10.1093/cid/ciad063
- By:
- Publication type:
- Article
Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 941, doi. 10.1093/cid/ciab125
- By:
- Publication type:
- Article
Incidence of Pharyngitis, Sinusitis, Acute Otitis Media, and Outpatient Antibiotic Prescribing Preventable by Vaccination Against Group A Streptococcus in the United States.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. e47, doi. 10.1093/cid/ciaa529
- By:
- Publication type:
- Article
Breastfeeding Duration and Cytomegalovirus Seroprevalence Among US Children Aged 1–5 Years: The National Health and Nutrition Examination Surveys, 2011–2012 and 2017–2018.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
The US Federal Retail Pharmacy Program: Optimizing COVID-19 Vaccine Delivery Through a Strategic Public–Private Partnership.
- Published in:
- Public Health Reports, 2023, v. 138, n. 6, p. 870, doi. 10.1177/00333549231186606
- By:
- Publication type:
- Article
Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020–July 2021.
- Published in:
- Public Health Reports, 2022, v. 137, n. 2, p. 239, doi. 10.1177/00333549211066168
- By:
- Publication type:
- Article
Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March-April 2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antibody Responses after Classroom Exposure to Teacher with Coronavirus Disease, March 2020.
- Published in:
- 2020
- By:
- Publication type:
- case study
Characteristics of Patients with Acute Flaccid Myelitis, United States, 2015-2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Streptococcus pneumoniae Serotype 15A in Psychiatric Unit, Rhode Island, USA, 2010-2011.
- Published in:
- Emerging Infectious Diseases, 2012, v. 18, n. 11, p. 1889, doi. 10.3201/eid1811.120454
- By:
- Publication type:
- Article
Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged ≤59 Months--Selected U.S. Regions, 2010-2011.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 22, p. 2449
- By:
- Publication type:
- Article
Infection Control Assessment of Ambulatory Surgical Centers.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 303, n. 22, p. 2273, doi. 10.1001/jama.2010.744
- By:
- Publication type:
- Article
Epidemiology of Invasive Pneumococcal Disease Among High-Risk Adults Since the Introduction of Pneumococcal Conjugate Vaccine for Children.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 5, p. e59, doi. 10.1093/cid/cis971
- By:
- Publication type:
- Article
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children.
- Published in:
- Pediatric Pulmonology, 2016, v. 51, n. 2, p. 157, doi. 10.1002/ppul.23221
- By:
- Publication type:
- Article
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 5, p. 1, doi. 10.1093/ofid/ofad187
- By:
- Publication type:
- Article
Regional Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Tract Infections in a Commercially Insured Population, United States, 2017.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 2, p. 1, doi. 10.1093/ofid/ofac584
- By:
- Publication type:
- Article
Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.
- Published in:
- Nature Genetics, 2012, v. 44, n. 3, p. 352, doi. 10.1038/ng.1072
- By:
- Publication type:
- Article
Use of an Additional Updated 2023--2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices -- United States, 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 16, p. 377, doi. 10.15585/mmwr.mm7316a4
- By:
- Publication type:
- Article
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged =18 Years with Immunocompromising Conditions -- VISION Network, September 2023-February 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 12, p. 271, doi. 10.15585/mmwr.mm7312a5
- By:
- Publication type:
- Article
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults -- Increasing Community Access to Testing Program, United States, September 2023-January 2024
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 4, p. 77, doi. 10.15585/mmwr.mm7304a2
- By:
- Publication type:
- Article
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease -- United States, September 2022-March 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 1, p. 16, doi. 10.15585/mmwr.mm7301a4
- By:
- Publication type:
- Article
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 42, p. 1140, doi. 10.15585/mmwr.mm7242e1
- By:
- Publication type:
- Article
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19--Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months--5 Years -- VISION Network, United States, July 2022--June 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 33, p. 886, doi. 10.15585/mmwr.mm7233a2
- By:
- Publication type:
- Article
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 24, p. 657, doi. 10.15585/mmwr.mm7224a3
- By:
- Publication type:
- Article
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions -- VISION Network, September 2022-April 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 21, p. 579, doi. 10.15585/mmwr.mm7221a3
- By:
- Publication type:
- Article
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years -- Increasing Community Access to Testing Program, United States, July 2022--February 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 7, p. 177, doi. 10.15585/mmwr.mm7207a3
- By:
- Publication type:
- Article
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 5, p. 119, doi. 10.15585/mmwr.mm7205e1
- By:
- Publication type:
- Article
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater -- New York, June-August 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 33, p. 1065, doi. 10.15585/mmwr.mm7133e2
- By:
- Publication type:
- Article
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated -- VISION Network, 10 States, December 2021-June 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 29, p. 931
- By:
- Publication type:
- Article
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years -- United States, June 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 26, p. 859, doi. 10.15585/mmwr.mm7126e2
- By:
- Publication type:
- Article
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant -- United States, February 14-March 27, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 18, p. 633
- By:
- Publication type:
- Article
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 13, p. 495, doi. 10.15585/mmwr.mm7113e2
- By:
- Publication type:
- Article
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines -- United States, February 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 11, p. 416, doi. 10.15585/mmwr.mm7111a4
- By:
- Publication type:
- Article
Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5–17 Years during the Delta and Omicron Periods—United States, December 2020 to April 2022.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0276409
- By:
- Publication type:
- Article
Strategies associated with COVID‐19 vaccine coverage among nursing home staff.
- Published in:
- Journal of the American Geriatrics Society, 2022, v. 70, n. 1, p. 19, doi. 10.1111/jgs.17559
- By:
- Publication type:
- Article
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites.
- Published in:
- PLoS Medicine, 2013, v. 10, n. 9, p. 1, doi. 10.1371/journal.pmed.1001517
- By:
- Publication type:
- Article
Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged ≤59 Months -- Selected U.S. Regions, 2010-2011.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2011, v. 60, n. 43, p. 1477
- By:
- Publication type:
- Article
Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 14, p. 1402, doi. 10.1001/jama.2022.14660
- By:
- Publication type:
- Article
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 327, n. 22, p. 2210, doi. 10.1001/jama.2022.7493
- By:
- Publication type:
- Article
First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Missed Opportunities: A National Survey of Obstetricians About Attitudes on Maternal and Infant Immunization.
- Published in:
- 2012
- By:
- Publication type:
- Report
Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997–2014.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 1, p. 30, doi. 10.1093/jpids/piy108
- By:
- Publication type:
- Article
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program -- United States, December 2020-January 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 5, p. 178, doi. 10.15585/mmwr.mm7005e2
- By:
- Publication type:
- Article
Limited Secondary Transmission of SARS-CoV-2 in Child Care Programs - Rhode Island, June 1-July 31, 2020.
- Published in:
- 2020
- By:
- Publication type:
- journal article
National Update on Measles Cases and Outbreaks - United States, January 1-October 1, 2019.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
- Published in:
- 2018
- By:
- Publication type:
- journal article